What We're Reading: Page 316
Industry reads hand-picked by our editors
Aug 17, 2016
Aug 16, 2016
-
Wall Street Journal
Chance collaboration yields an advance in cancer treatment
-
BloombergGadfly
Read the Label on Pharma's New Drug Sales
-
Stat
5 ways drug makers and the health care industry are shaping campaigns
-
New Yorker
The race for a Zika vaccine
Aug 15, 2016
-
Financial Times
Scientists welcome Brexit funding commitment
-
Reuters
Delaware court backs UCB drug patent, shares jump
-
Stat
Whistleblower case contends surgical device maker misled FDA — and patients paid the price
-
Boston Business Journal
Cambridge drugmaker Moderna weighs Norwood as site for new R&D, manufacturing facility
Aug 12, 2016
Aug 11, 2016
-
New York Times
Driven to suicide by an 'inhuman and unnatural pressure' to sell
-
GEN
Mental Immunity: The Microbiome’s Influence on Two Critical Body Systems
-
Regulatory Focus
Everything you need to know about biosimilars
-
Stat
Hospitals are throwing out organs and denying transplants to meet federal standards
Aug 10, 2016
Aug 09, 2016
-
MIT Technology Review
Gene-Therapy Cure Has Money-Back Guarantee
-
BloombergGadfly
Allergan's buying something, if not Biogen
-
Reuters
Future of drug pricing: paying for benefits not per pill
-
Nature
Beyond CRISPR: A guide to the many other ways to edit a genome
Previous
